NCT07091864 - Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

July 29, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions

Glioblastoma, IDH-WildtypeWHO Grade 4 Glioma

Interventions

OTHER

Best Practice

Receive SOC treatment

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

OTHER

Dietary Intervention

Attend dietary counseling sessions

OTHER

Glucose Measurement

Undergo intermittent glucose monitoring

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Monitoring

Undergo CGM

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Supportive Care

Receive endocrinology-guided interventions

Trial Locations (1)

RECRUITING

Mayo Clinic in Rochester, Rochester